BioAge Labs Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
BIOA$5.69+6.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
|---|---|---|---|---|---|---|
| 3.1 · Restated Certificate of Incorporation. · X | ||||||
| 3.2 · Restated Bylaws. · X | ||||||
| 4.1 | Form of Common Stock Certificate. | S-1 | 333-281901 | 4.1 | 09/03/2024 | |
| 10.1 | Form of Indemnity Agreement. | S-1/A | 333-281901 | 10.1 | 09/18/2024 | |
| 10.2 | 2024 Equity Incentive Plan and forms of award agreements. | S-1/A | 333-281901 | 10.3 | 09/18/2024 | |
| 10.3 | 2024 Employee Stock Purchase Plan and forms of award agreements. | S-1/A | 333-281901 | 10.4 | 09/18/2024 | |
| 10.4 | Change in Control and Severance Plan. | S-1/A | 333-281901 | 10.5 | 09/18/2024 | |
| 10.5 | Offer Letter by and between the Registrant and Kristen Fortney, dated September 17, 2024. | S-1/A | 333-281901 | 10.10 | 09/18/2024 | |
| 10.6 | Offer Letter by and between the Registrant and Eric Morgen, dated September 17, 2024. | S-1/A | 333-281901 | 10.11 | 09/18/2024 | |
| 10.7 | Offer Letter by and between the Registrant and Paul Rubin, dated September 17, 2024. | S-1/A | 333-281901 | 10.12 | 09/18/2024 | |
| 10.8 | Share Purchase Agreement, dated as of September 25, 2024, by and among Company and the Purchaser. | 8-K | 001-42279 | 10.1 | 09/27/2024 | |
| 10.9 | Office and Laboratory Lease by and between the Company and ES East, LLC, dated August 23, 2024. | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | ||||
- This certification is deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.